Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 4;10(1):584.
doi: 10.1038/s41467-019-08388-7.

Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts

Affiliations

Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts

Meredith A Redd et al. Nat Commun. .

Abstract

Vascularization and efficient perfusion are long-standing challenges in cardiac tissue engineering. Here we report engineered perfusable microvascular constructs, wherein human embryonic stem cell-derived endothelial cells (hESC-ECs) are seeded both into patterned microchannels and the surrounding collagen matrix. In vitro, the hESC-ECs lining the luminal walls readily sprout and anastomose with de novo-formed endothelial tubes in the matrix under flow. When implanted on infarcted rat hearts, the perfusable microvessel grafts integrate with coronary vasculature to a greater degree than non-perfusable self-assembled constructs at 5 days post-implantation. Optical microangiography imaging reveal that perfusable grafts have 6-fold greater vascular density, 2.5-fold higher vascular velocities and >20-fold higher volumetric perfusion rates. Implantation of perfusable grafts containing additional hESC-derived cardiomyocytes show higher cardiomyocyte and vascular density. Thus, pre-patterned vascular networks enhance vascular remodeling and accelerate coronary perfusion, potentially supporting cardiac tissues after implantation. These findings should facilitate the next generation of cardiac tissue engineering design.

PubMed Disclaimer

Conflict of interest statement

C.E.M. is a scientific founder and equity holder in Cytocardia. R.K.W. discloses intellectual property (US8180134 In vivo structural and flow imaging (2006), US9013555 Method and apparatus for ultrahigh sensitive optical microangiography (2009)) owned by the Oregon Health and Science University and the University of Washington related to OCT angiography, and licensed to commercial entities, which are related to the technology and analysis methods described in part of this manuscript. R.K.W. also receives research support from Carl Zeiss Meditec Inc, Moptim Inc, Facebook Technologies LLC, and Colgate Palmolive Company. He is a consultant to Insight Photonic Solutions, Kowa, and Carl Zeiss Meditec. All the other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
In vitro anastomosis of human embryonic stem cell-derived endothelial cells (hESC-ECs) in engineered microvessels (µVs). a Schematic of in vitro culture device for μV+SA constructs: mTm-hESC-EC µVs formed via perfusion and attachment with bulk-seeded GFP-hESC-ECs in the surrounding collagen gel. b Maximum intensity projection of stitched large image confocal z-stack of μV+SA construct cultured for 4 days and stained for DsRed (red) and GFP (green) to detect mTm- and GFP-expressing hESC-ECs, respectively. Scale bar, 500 μm. c Outlined region (white box) in b stained for DsRed (red, top left), GFP (green, top right), and VE-cadherin (white, bottom left). Merged image, bottom right. Scale bar, 200 μm. d High magnification images of GFP-hESC-ECs (green) integrated with mTm-hESC-EC (red) patterned vessel in μV+SA constructs. Scale bar, 50 μm. e Quantitation of sprouts from patterned µVs by sprout density (no. of sprouts per vessel surface area), sprout length, and sprout diameter in μV only (blue circles) and μV+SA (green circles) constructs after 4 days and 7 days of culture. N = 6, 7, 4, and 3 biologically independent samples for D4 μV only, D4 μV+SA, D7 μV only, and D7 μV+SA, respectively. p = 0.011 for length and p = 0.007 for diameter for D4 μV only and D7 μV only, p > 0.05 for all others (two-tailed t test). f 3D view of GFP+ de novo lumen integrated with mTm+ microvascular sprout (white arrowheads) stained for CD31 (red) and GFP (green). Scale bar, 100 μm. Representative images for bd, f from seven biologically independent samples of D4 μV+SA, with similar results. Hoechst-stained nuclei, blue. Error bars, mean ± SEM. *p < 0.05 determined using two-tailed t test. D4 after 4 days of culture, D7 after 7 days of culture
Fig. 2
Fig. 2
Fluorescent bead perfusion of engineered microvessels (µVs). a µV+SA construct with perfused anastomotic connections. High magnification views of outlined regions i and ii with corresponding in situ staining for mTm-hESC-ECs (DsRed+, red) and GFP-hESC-ECs (GFP+, green). Scale bars, 100 μm, 40 μm. b High magnification view of fluorescent beads at two time points, t0 and t1, 0.27 s apart. Red arrows track the movement of fluorescent beads to calculate velocities. c, d Average bead velocity in the patterned vessel (c) and in sprouts with diameter <50 µm (d) in µV only (blue circles) and µV+SA (green circles) constructs after 4 days and 7 days of culture N = 3, 3, 4, and 3 biological independent samples for D4 µV only, D4 µV+SA, D7 µV only, and D7 µV+SA, respectively. p = 0.004 for D4 µV+SA and D7 µV+SA in sprouts, p = 0.012 for D7 µV and D7 µV+SA in sprouts, p > 0.05 for all others (two-tailed t test). e Scatter plot of bead velocity in relation to sprout diameter N = 15, 20, 37, 53 (number of sprouts analyzed) for D4 µV only, D4 µV+SA, D7 µV only, and D7 µV+SA in 2, 1, 5, and 3 biologically independent samples. Representative images for a, b from three biologically independent samples of D4 µV+SA, with similar results. Hoechst-stained nuclei, blue. Error bars, mean ± SEM. *p < 0.05 determined using two-tailed t test. ns non-significant (p > 0.05). D4 after 4 days of culture, D7 after 7 days of culture
Fig. 3
Fig. 3
Citrated whole-blood perfusion in engineered microvessels (µVs). a Brightfield stitched large image of red blood cell-filled pattern and sprouts with magnified view (inset, white dotted boundary) for human embryonic stem cell-derived endothelial cell (hESC-EC)-seeded µV only constructs after 4 days of culture. Scale bar, 200 μm. b Maximum intensity projection of confocal z-stack of constructs with adhered platelets after 30-min perfusion and subsequent phosphate-buffered saline (PBS) washes for untreated hESC-EC-seeded constructs (top) and phorbol myristate acetate (PMA)-treated hESC-EC-seeded constructs (bottom) stained for CD31 (red) and CD41a (green). Scale bar, 200 μm. c Quantification of platelet adhesion on the vessel wall for constructs seeded with human umbilical vein endothelial cells (HUVECs) in control conditions (C–HUVEC), hESC-ECs in control conditions (C–hESC-EC), and hESC-ECs treated with PMA (PMA–hESC-EC) or interleukin (IL)-1β (IL-1β–hESC-EC). Data are expressed as a percentage of the vessel wall surface area. N = 2, 2, 2, and 3 biologically independent samples for C–HUVEC, C–hESC-EC, PMA, and IL-1β, respectively. Representative images for a, b from two biologically independent samples of C–hESC-ECs and two biologically independent samples of PMA–hESC-EC, with similar results. Error bars, mean ± SEM
Fig. 4
Fig. 4
Global RNA sequencing reveals differential gene expression profiles among self-assembled (SA), µV only, and µV+SA constructs after 3 days of culture in vitro. a 2D principal component analysis (PCA) of RNA sequencing data for cultured constructs showing clustered groups for each condition. b, c Top genes contributing to PC1: b Size of the circle is proportional to the contribution. c Heat map of the top 75 genes (log2 CPM) contributing to PC1 in categorized functions. Colormap normalized to minimum and maximum expression. Red, high expression. Blue, low expression. d Gene ontology terminology analysis (GO) showing different gene clusters for μV+SA vs. SA (left) and μV vs. SA (right). Each sample is two constructs pooled. CPM counts per million
Fig. 5
Fig. 5
Implanted vascular constructs in infarcted rat heart model with optical microangiography (OMAG) assessment of real-time perfusion 5 days post-implantation. ac Doppler-based images of vascular flow in Langendorff perfused engrafted hearts for a healthy region, b control graft (self-assembled (SA)), and c patterned, perfusable graft (μV+SA). Top panels, high-resolution, non-quantitative OMAG images. Bottom panels, OMAG-V images with linear correlation between intensity and velocity. Scale bar, 500 μm. d Three-dimensional views of OMAG flow data and overlay of OMAG structure and flow data for SA graft and μV+SA graft. Scale bar, 500 μm. e Quantitation of vessel density of perfused vessels in healthy (red circles) and graft (purple circles) regions for SA and μV+SA. N = 9 and 8 biologically independent animals for SA and μV+SA, respectively. p = 0.0009 for SA healthy and graft, p = 0.0016 for μV+SA healthy and graft, p = 0.0012 for SA and μV+SA graft, p > 0.05 for all others (two-tailed t test). f Velocimetry measurements of blood flow velocity in small arterioles (diameter between 20 and 40 μm) of healthy and graft regions. N = 5 and 6 biologically independent animals for SA and μV+SA, respectively. p = 0.016 for SA healthy and graft, p = 0.023 for SA and μV+SA graft, p > 0.05 for all others (two-tailed t test). g Volumetric perfusion rate in SA and μV+SA grafts from velocimetry data. N = 5 and 6 biologically independent animals for SA and μV+SA, respectively. p = 0.038 for SA and μV+SA graft (two-tailed t test). Representative images for ad from 5 biologically independent animals containing SA grafts, 6 biologically independent animals containing μV+SA grafts, and 11 corresponding healthy regions from all animals containing grafts, with similar results. Error bars, mean ± SEM. *p < 0.05, **p < 0.01 determined using two-tailed t test
Fig. 6
Fig. 6
Detection of human endothelial cells and perfused vessels in grafts 5 days post-implantation. a, b Immunofluorescent-stained paraffin sections of self-assembled (SA) and µV+SA grafts: a human embryonic stem cell-derived endothelial cells (hESC-ECs) (DsRed+, red) and perfused rat and human endothelium (Lectin+, green). White arrows in merged images denote double positive cells. Scale bar, 100 μm. b hESC-ECs (DsRed+, red) and perfused human endothelium (UEA I+, white). Yellow arrows in merged images denote double positive cells. Scale bar, 100 μm. c Quantification of vessel density (number of vessels per mm2) and average vessel size for hESC-EC vessels (DsRed+, red circles) and all perfused vessels (Lectin+, blue circles) in the grafts. N = 6 biologically independent animals for both SA and µV+SA grafts. p = 0.045 for lectin+ vessels for SA and µV+SA, p = 0.018 for DsRed+ and lectin+ for µV+SA, p > 0.05 for all others (two-tailed t test). d Quantification of vessel density and average vessel size of perfused human vessels (UEA I+, grey circles) in the grafts. N = 6 biologically independent animals for both SA and µV+SA grafts, with one animal with µV+SA graft excluded from vessel size calculation due to lack of UEA I+ vessels. p = 0.023 for vessel size for SA and µV+SA, p > 0.05 for vessel density (two-tailed t test). Representative images for a, b from six biologically independent animals containing SA grafts and six biologically independent animals containing μV+SA grafts, with similar results. Hoechst-stained nuclei, blue. Data were collected from at least three confocal images of randomly selected regions per sample and analyzed by a custom lumen identifying code for vessel density and size. Error bars, mean ± SEM. *p < 0.05 determined using two-tailed t test. UEA Ulex europaeus Agglutinin I
Fig. 7
Fig. 7
Perfusable cardiac constructs in infarcted rat heart model 5 days post-implantation a, b Immunofluorescent-stained paraffin sections of self-assembled (SA; left) and µV+SA (right) cardiac grafts: a Whole-graft section containing human embryonic stem cell-derived cardiomyocytes (hESC-CMs) (β-MHC, red). Gray dotted line outlines graft tissue. Scale bar, 1 mm. b High magnification images of boxed region in a (yellow box) with hESC-CMs (β-MHC, red, bottom right) and perfused vessels (Lectin+, green, bottom left). Merged, top. Scale bar, 100 μm. c Quantification of cardiomyocyte density (number of β-MHC+ cells per mm2) and β-MHC+ graft size (% LV area). N = 7 and 6 biologically independent animals for SA and µV+SA, with one animal with µV+SA graft excluded from graft size calculation due to partial graft removal during tissue processing. p = 0.015 for density, p > 0.05 for graft size (two-tailed t test). d Quantification of vessel density (number of vessels per mm2) and average vessel size for all perfused vessels (Lectin+) in the cardiac grafts. N = 7 and 6 biologically independent animals for SA and µV+SA, respectively. p = 0.046 for vessel density, p > 0.05 for vessel size (two-tailed t test). e Terminal deoxinucleotidyl transferase-mediated dUTP-fluorescein nick end labeling (TUNEL) assay for apoptotic cells (TUNEL, green) on paraffin sections of SA (left) and µV+SA (right) cardiac grafts. Scale bar, 100 μm. f Quantification of apoptotic cells (TUNEL+) as a percentage of all cells (human and host) in the graft. N = 7 and 6 biologically independent animals for SA and µV+SA, respectively. p > 0.05 (two-tailed t test). Representative images for a, b, e from six biologically independent animals containing SA grafts and five biologically independent animals containing μV+SA grafts, with similar results. Hoechst-stained nuclei, blue. Data were collected from at least two confocal images of randomly selected regions per sample. Images analyzed by a custom lumen identifying code for vessel density and size. Error bars, mean ± SEM. *p < 0.05 determined using two-tailed t test. β-MHC beta-myosin heavy chain

References

    1. MacNeil S. Progress and opportunities for tissue-engineered skin. Nature. 2007;445:874–880. doi: 10.1038/nature05664. - DOI - PubMed
    1. Atala A. Engineering organs. Curr. Opin. Biotechnol. 2009;20:575–592. doi: 10.1016/j.copbio.2009.10.003. - DOI - PubMed
    1. Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Sci. Transl. Med. 2012;4:160rv12. doi: 10.1126/scitranslmed.3004890. - DOI - PubMed
    1. Ogle BM, et al. Distilling complexity to advance cardiac tissue engineering. Sci. Transl. Med. 2016;8:342ps13. doi: 10.1126/scitranslmed.aad2304. - DOI - PMC - PubMed
    1. Laflamme Ma, Murry CE. Heart regeneration. Nature. 2011;473:326–335. doi: 10.1038/nature10147. - DOI - PMC - PubMed

Publication types